📣 VC round data is live. Check it out!
- Public Comps
- Quantum-Si
Quantum-Si Valuation Multiples
Discover Quantum-Si's revenue and EBITDA valuation multiples and M&A history, alongside public comparables like OraSure, Eurobio Scientific, Carlsmed, Alpha Teknova and more.
Quantum-Si Overview
About Quantum-Si
Quantum-Si Inc is a life sciences company focused on the development and commercialization of proteomics research tools. The company has designed and developed a hardware, consumable, and software solution to provide a solution for protein detection and analysis. It has developed a proprietary universal single-molecule detection platform that enables Next-Generation Protein Sequencing (NGPS), the ability to sequence proteins.
Founded
2013
HQ

Employees
149
Website
Financials (LTM)
EV
$143M
Valuation Multiples
Start free trialQuantum-Si Financials
Quantum-Si reported last 12-month revenue of $2M and negative EBITDA of ($85M).
In the same LTM period, Quantum-Si generated $783K in gross profit, ($85M) in EBITDA losses, and had net loss of ($100M).
Revenue (LTM)
Quantum-Si P&L
In the most recent fiscal year, Quantum-Si reported revenue of $2M and EBITDA of ($81M).
Quantum-Si is unprofitable as of last fiscal year, with gross margin of 47%, EBITDA margin of (3313%), and net margin of (4160%).
Financial data powered by Morningstar, Inc.
Quantum-Si Stock Performance
Quantum-Si has current market cap of $267M, and enterprise value of $143M.
Market Cap Evolution
Quantum-Si's stock price is $1.22.
Quantum-Si share price increased by 2.5% in the last 30 days, and decreased by 37.5% in the last year.
Quantum-Si has an EPS (earnings per share) of $-0.47.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $143M | $267M | 3.8% | 2.5% | 58.3% | -37.5% | $-0.47 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialQuantum-Si Valuation Multiples
Quantum-Si trades at 77.6x EV/Revenue multiple, and (1.7x) EV/EBITDA.
EV / Revenue (LTM)
Quantum-Si Financial Valuation Multiples
As of June 3, 2026, Quantum-Si has market cap of $267M and EV of $143M.
Quantum-Si has a P/E ratio of (2.7x).
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Quantum-Si Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Quantum-Si Margins & Growth Rates
Quantum-Si decreased revenue by 58% but EBITDA grew by 13% in the last fiscal year.
In the most recent fiscal year, Quantum-Si reported gross margin of 47%, EBITDA margin of (3313%), and net margin of (4160%).
Quantum-Si Margins
Quantum-Si Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
Quantum-Si Operational KPIs
Quantum-Si's revenue per employee in the last FY averaged $0.0M, while opex per employee averaged $0.7M for the same period.
Quantum-Si's Rule of 40 is (8924%) (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Quantum-Si's Rule of X is (9010%) (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Data powered by FactSet, Inc. and Morningstar, Inc.
Quantum-Si Competitors
Quantum-Si competitors include OraSure, Eurobio Scientific, Carlsmed, Alpha Teknova, Carvolix, Ascom, Median Technologies, Dong-A ST, Shoulder Innovations and Stratec.
Most Quantum-Si public comparables operate across Medical Devices, Life Sciences Tools, DeepTech, HealthTech and Quantum Computing.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| 1.0x | 0.9x | (2.7x) | (2.7x) | |||
| 1.3x | 1.3x | 7.8x | 7.3x | |||
| 3.9x | 3.2x | (7.1x) | (6.4x) | |||
| 7.1x | 6.8x | (42.8x) | (39.5x) | |||
| 57.0x | 401.8x | (19.6x) | (12.8x) | |||
| 0.7x | 0.7x | 5.9x | 6.0x | |||
| 9.3x | 8.8x | (13.7x) | (13.8x) | |||
| 0.8x | 0.8x | 11.0x | 10.4x | |||
This data is available for Pro users. Sign up to see all Quantum-Si competitors and their valuation data. Start Free Trial | ||||||
Acquisitions by Quantum-Si
Quantum-Si has acquired 1 company to date.
Last acquisition by Quantum-Si was on November 9th 2021. Quantum-Si acquired Majelac Technologies for $10M (EV/Revenue multiple available to Pro users).
Latest Acquisitions by Quantum-Si
| Description | Majelac Technologies is an Italian firm specializing in assembly equipment for the semiconductor sector, including die bonders and wafer handling systems. Based in Milan area, it supplies precision machinery to fabs in Europe and Asia for high-volume production of chips used in automotive and consumer electronics. |
| HQ Country | |
| HQ City | Philadelphia, PA |
| Deal Date | 9 Nov 2021 |
| Valuation | $10M |
| EV/Revenue | |
| EV/EBITDA | |
This data is available for Pro users. Sign up to see all Quantum-Si acquisitions and their M&A valuation multiples. Start Free Trial | |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Quantum-Si
| Who are competitors of Quantum-Si? | Quantum-Si main competitors include OraSure, Eurobio Scientific, Carlsmed, Alpha Teknova, Carvolix, Ascom, Median Technologies, Dong-A ST, Shoulder Innovations, Stratec. |
See public comps similar to Quantum-Si
Lists including Quantum-Si
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.
